Pureos Bioventures
VC Firm•Series A/B, Series C & Beyond • Switzerland
Pureos Bioventures is a venture capital fund, which invests exclusively in private innovative drug development companies, with a special emphasis on the next generation of biological drugs and drug formats. The fund’s portfolio companies are built on scientific excellence to develop therapies across a broad indication spectrum including oncology, immunology, ophthalmology, rare diseases, and neuroscience. Pureos has built a team with deep investment, operating and clinical expertise, that strives to impact patients’ lives by advancing innovative treatments for devastating diseases.
Investment Areas
Typical Investment
Above €3M
Funding Stage
Series A/B, Series C & Beyond
Headquarters
Switzerland

